Resources with keywords: covid-19
Key Points include strategies for contingency capacity
This guidance applies to all U.S. settings where healthcare is delivered, including nursing homes and home health. The recommendations in this guidance continue to apply after the expiration of the federal COVID-19 Public Health Emergency.
Currently there remains a lack of regulatory alignment among OSHA, the Food and Drug Administration (FDA), and the National Institute for Occupational Safety and Health (NIOSH) regarding respirator approval for use in health care.
This guidance is intended for clinical laboratory and support staff who handle or process specimens associated with COVID-19.
Discusses the disease, prevention via vaccination, signs and symptoms, complications, testing and diagnosis, who is most at risk, etc.
Gillum D, et al.
The US government issued a long-awaited policy update last month intended to better manage the hazards associated with risky biological research.
International experts reach consensus on a set of descriptors to describe how pathogens are transmitted through the air and the related modes of transmission.
In general, asymptomatic healthcare personnel (HCP) who have had a higher-risk exposure do not require work restriction, regardless of vaccination status, if they do not develop symptoms or test positive for SARS-CoV-2.
